Conferences - Results from #680

Viewing 681-700 of 11775 articles

APCCC 2024: When to Do Tumor Genomic Profiling in Advanced Prostate Cancer and What?

APCCC 2024: Future Changes in the Setting of mHSPC

APCCC 2024: How to Manage Patients with Low-Volume on Conventional and High-Volume on Next Generation Imaging

APCCC 2024: Management of Frail Patients with mHSPC

APCCC 2024: Management of Patients with mHSPC and Early Progression on Combination Therapy

APCCC 2024: Genomic Classifiers and Artificial Intelligence as Predictors for Treatment Benefit

APCCC 2024: Which Patients with mHSPC Can Be Offered a Treatment Break (De-Escalation Strategies) and How to Manage the Break?

APCCC 2024: Escalation Strategies in Patients with mHSPC and an Unfavourable PSA Decline – Is More Better?

APCCC 2024: Update on the IRONMAN Project

APCCC 2024: Debate: How to Best Manage a Fit Patient with High-Risk Localised and Locally Advanced Prostate Cancer? Surgery as Radical Local Treatment (As Part of a Multimodality Approach)

APCCC 2024: In Which Patients with Metachronous Low-volume mHSPC Do You Recommend “total Therapy”?

APCCC 2024: In Which Patients with Synchronous Low-Volume mHSPC Do You Recommend “Total Therapy”?

APCCC 2024: Should the Primary Be Treated in Synchronous High-Volume mHSPC

APCCC 2024: Radiation Therapy Schedules and Fields for High-Risk and Locally Advanced Prostate Cancer

APCCC 2024: Introduction to mHSPC – What Are Relevant Prognostic/Predictive Factors for the Management of Patients?

APCCC 2024: Synchronous Low-volume mHSPC – In Which Patients Do You Recommend Combination Systemic Therapy Plus Local Treatment of the Primary and in Which Patients is ADT Alone Plus Radiotherapy Enough?

APCCC 2024: In Patients Who Receive Salvage Radiation Therapy for BCR, Who Needs Additional Systemic Therapy, What and for How Long?

APCCC 2024: Which Patients with High-Risk First BCR after Radical Prostatectomy Are Candidates for Systemic Therapy Alone Without Local Salvage Radiotherapy?

APCCC 2024: Second BCR (Without Correlate on NGI) After Salvage Radiation And/or After Metastases Directed Therapy: How to Manage These Patients?

APCCC 2024: In Patients with BCR and Positive Lesion(s) in the Pelvis – Stereotactic or Whole Pelvis Radiotherapy?

30
31
32
33
34
35
36
37
38
39